Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cangrelor versus Ticagrelor for Early Platelet Inhibition in ST-Elevation Myocardial Infarction
2016-003721-41Phase 4Terminated
- Sponsor
- Aarhus University Hospital
- Start
- Nov 2017
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in acute ST-segment elevation myocardial infarction (STEMI) comparing Intravenous cangrelor with Oral ticagrelor (2 arms). Started Nov 2017; status: terminated.
02
Drugs
cangrelorticagrelor
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on 2016-003721-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003721-41.